University Hospitals Receives $10 Million Gift For Rainbow NICU and Neurological Institute
Wednesday, June 28, 2006 (528 reads)
CLEVELAND -- University Hospitals Health System today announced a $10 million gift from The Elisabeth Severance Prentiss Foundation. The Foundation has designated $7 million to support the new Neonatal Intensive Care Unit (NICU) at Rainbow Babies & Children’s Hospital, and $3 million for further development of The Neurological Institute at University Hospitals.
"The plans that UH has outlined for the future of the hospital system in its Vision 2010 growth strategy are among the best we have ever seen," said Elisabeth Severance Prentiss Foundation trustees in making this gift. "We hope our philanthropic investment will inspire others in the community to step up and join us in supporting University Hospitals in its efforts to raise healthcare to new heights in Northeast Ohio."
 Read More |
|
Komen Foundation Grant Funds Breast Cancer Outreach
Tuesday, June 20, 2006 (648 reads)
CLEVELAND -- The Ireland Cancer Center of University Hospitals of Cleveland has received a $115,000 grant from the Susan G. Komen Breast Cancer Foundation Northeast Ohio Affiliate to combat racial disparities in breast cancer. The grant will support Project T.E.M.P.L.E. (Teaching-Educating-Mentoring-Preventing-Learning-Empowering), a breast health education program for minority and low-income women in Cleveland’s urban areas.
 Read More |
|
University Hospitals Receives $1.75 Million for Childhood Cancer
Wednesday, June 07, 2006 (662 reads)
University Hospitals of Cleveland (UHC) announced two philanthropic gifts today to advance childhood cancer programs. Karen and Larry Vassil of Richfield, Ohio, pledged $1 million to meet and exceed a $750,000 challenge grant from The Skirball Foundation of New York. The Vassils’ gift is in honor of their daughter, Hilary, a cancer survivor. The combined gifts will fund the Jack H. and William N. Skirball Fellowship in Pediatric Hematology and Oncology at Rainbow Babies & Children’s Hospital and the Ireland Cancer Center of UHC.
Read More |
|
Researchers Announce New Predictor for Lung Cancer Treatment and Survival
Monday, June 05, 2006 (625 reads)
CLEVELAND -- Research from the Ireland Cancer Center of University Hospitals of Cleveland has found a promising, novel biomarker that may be used to predict the survival of patients with advanced lung cancer and their response to treatment. Afshin Dowlati, MD, hematologist/ oncologist at the Ireland Cancer Center, presented this study June 5 at the annual meeting of the American Society of Clinical Oncology (ASCO).
Read More |
|